CAS: 1429515-59-2; 4-((7H-Pyrrolo[2,3-D]Pyrimidin-4-yl)Amino)-N-(4-((4-Methylpiperazin-1-yl)Methyl)Phenyl)-1H-Pyrazole-3-Carboxamide

主要参考文献

1: Zou D, Hu B, Feng S, Si R, Zhong B, Shen B, Du Y, Feng J. FN-1501 Inhibits Diffuse Large B-Cell Lymphoma Tumor Growth by Inducing Cell Cycle Arrest and Apoptosis. Anticancer Agents Med Chem. 2024;24(20):1501-1513. doi: 10.2174/0118715206345788240902062910. 13(12):6026-6037.
3: Richardson GE, Al-Rajabi R, Uprety D, Hamid A, Williamson SK, Baranda J, Mamdani H, Lee YL, Nitika, Li L, Wang X, Dong X. A Multicenter, Open-Label, Phase I/II Study of FN-1501 in Patients with Advanced Solid Tumors. Cancers (Basel). 2023 Apr 29;15(9):2553. doi: 10.3390/cancers15092553.
4: Kumarasamy V, Gao Z, Zhao B, Jiang B, Rubin SM, Burgess K, Witkiewicz AK, Knudsen ES. PROTAC-mediated CDK degradation differentially impacts cancer cell cycles due to heterogeneity in kinase dependencies. Br J Cancer. 2023 Oct;129(8):1238-1250. doi: 10.1038/s41416-023-02399-4. Epub 2023 Aug 25.

合成参考文献

参考文献:10.1021/acs.jmedchem.1c01196
摘要:Wang Z, Cai J, Ren J, Chen Y, Wu Y, Cheng J, Jia K, Huang F, Cheng Z, Sheng T, Song S, Heng H, Zhu Y, Tang W, Li H, Lu T, Chen Y, Lu S. Discovery of a Potent FLT3 Inhibitor (LT-850-166) with the Capacity of Overcoming a Variety of FLT3 Mutations. J Med Chem. 2021 Oct 14;64(19):14664–701. doi: 10.1021/acs.jmedchem.1c01196.